These tweets are selected automatically with #rstats code. Please inform me if any is inappropriate. See other #USCAP pages here: https://serdarbalci.netlify.com/categories/USCAP/ or here: https://serdarbalci.wordpress.com/?s=USCAP/ See selected social media based textbook project here: http://www.patolojinotlari.com/
What a morning!
— رنا الدريس Rana Aldrees (@RanaAldreesMD) March 3, 2020
A Primer in Precision Pathology: Genomics, Al and Immuno-oncology with @DrNetto, @SchnittStuart, @PathPro and others at #USCAP2020 @TheUSCAP pic.twitter.com/rq88lRqJhX
RT PhysRelations "RT sanamloghavi: Dr. Hong Fang from MDAndersonNews #HemepathMDA presenting data on MDS and AML with t(6;9) suggesting Allo-HSCT abrogates the difference in survival between the MDS and AML groups. #leusm #USCAP2020 pic.twitter.com/kkPHclh6OI"
— Robert Z. Orlowski (@Myeloma_Doc) March 3, 2020
RT PhysRelations "RT TashakoriM: Happening now: precision Dx and modern Tx in AML by amazing Dr. Bueso-Ramos and Dr. Daver_Leukemia from MDAndersonNews #USCAP2020 #Leukemia pic.twitter.com/ijyn6loVPj"
— Robert Z. Orlowski (@Myeloma_Doc) March 3, 2020
#USCAP2020 #ModeratedPosters pic.twitter.com/O2e2frZOng
— Julie Feldstein,M.D., FCAP (@feldstej) March 2, 2020
9p24.1/PDL1 Amplification and Checkpoint Molecule Expression in T-Cell Lymphomas#USCAP2020 https://t.co/6GavKvkitP
— Julie Feldstein,M.D., FCAP (@feldstej) March 2, 2020
LACC 403 A
Platform
Peripheral T-Cell Lymphomas are Characterized by Transcriptionally Active FOXO3
— Julie Feldstein,M.D., FCAP (@feldstej) March 2, 2020
#USCAP2020
LACC West Exhibit Hall A
Poster 286 Presentation https://t.co/tBzRE9gUPO pic.twitter.com/DCMomLRg1B
Utility of Lymphoid Enhancer-Binding Factor -1 (LEF-1) Expression by Immunohistochemistry in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma
— Julie Feldstein,M.D., FCAP (@feldstej) March 2, 2020
#USCAP2020
LACC West Exhibit Hall A
Poster 292 Presentation https://t.co/tBzRE9gUPO pic.twitter.com/vsfmS4iNKk
#USCAP2020 #EveningSpecialties pic.twitter.com/h1H0RKYAfI
— Julie Feldstein,M.D., FCAP (@feldstej) March 2, 2020
Features of Hepatic Lymphoma: A 16-Year Retrospective Study on 90 Patients from a Single Center #USCAP2020
— Julie Feldstein,M.D., FCAP (@feldstej) March 2, 2020
https://t.co/tBzRE9gUPO
LACC West Exhibit Hall A
Poster 288 Presentation Stowell Orbison
Patterns of Expression of PD-1, CXCL13, ICOS, CD10, and BCL-6 in AITL, PTCL, TCRBCL, PTGC, and RLH
— Julie Feldstein,M.D., FCAP (@feldstej) March 2, 2020
#USCAP2020
LACC West Exhibit Hall A
Poster 289 Presentation https://t.co/tBzRE9gUPO
#USCAP2020 #MountSinai pic.twitter.com/AlFSkbA2tF
— Julie Feldstein,M.D., FCAP (@feldstej) March 2, 2020
#EyesOnYou #USCAP2020 pic.twitter.com/tWzijtJ5wW
— Julie Feldstein,M.D., FCAP (@feldstej) March 2, 2020
Comparison of the Performance of Two Different ALK Antibody Clones (D5F3 and ALK1) in Anaplastic Large Cell Lymphoma (ALCL)
— Julie Feldstein,M.D., FCAP (@feldstej) March 2, 2020
#USCAP2020
LACC West Exhibit Hall A
Poster 305 Presentation
Ok, making the #USCAP2020 calendar today. If any if you #PathTwitterati have some must-dos, get 'em out there!
— Peter Sadow, MD, PhD (@PathDocBoston) February 27, 2020
These tweets are selected automatically with #rstats code. Please inform me if any is inappropriate. See other #USCAP pages here: https://serdarbalci.netlify.com/categories/USCAP/ or here: https://serdarbalci.wordpress.com/?s=USCAP/ See selected social media based textbook project here: http://www.patolojinotlari.com/
)